Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 154

1.

Mechanisms, Evaluation, and Management of Chronic Constipation.

Bharucha AE, Lacy BE.

Gastroenterology. 2020 Apr;158(5):1232-1249.e3. doi: 10.1053/j.gastro.2019.12.034. Epub 2020 Jan 13. Review.

PMID:
31945360
2.

Patient-Centric Care of Diarrhea-Predominant Irritable Bowel Syndrome.

Lacy BE.

J Fam Pract. 2019 Oct;68(8):S43-S48. No abstract available.

PMID:
31697799
3.

Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions.

Cangemi DJ, Lacy BE.

Therap Adv Gastroenterol. 2019 Oct 4;12:1756284819878950. doi: 10.1177/1756284819878950. eCollection 2019. Review.

4.

Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose.

Snyder DL, Crowell MD, Horsley-Silva J, Ravi K, Lacy BE, Vela MF.

Am J Gastroenterol. 2019 Sep;114(9):1464-1469. doi: 10.14309/ajg.0000000000000369.

PMID:
31403963
5.

Gastrointestinal Manifestations of Rheumatological Diseases.

Kröner PT, Tolaymat OA, Bowman AW, Abril A, Lacy BE.

Am J Gastroenterol. 2019 Sep;114(9):1441-1454. doi: 10.14309/ajg.0000000000000260. Review.

PMID:
31205138
6.

Introduction to the Gut Microbiome Special Issue.

Lacy BE, Spiegel B.

Am J Gastroenterol. 2019 Jul;114(7):1013. doi: 10.14309/ajg.0000000000000303. No abstract available.

PMID:
31205134
7.

Response to Lai.

Cash BD, Lacy BE, Schoenfeld PS, Dove LS, Covington PS.

Am J Gastroenterol. 2019 Jul;114(7):1177-1178. doi: 10.14309/ajg.0000000000000312. No abstract available.

PMID:
31205133
8.

Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials.

Lacy BE, Harris LA, Chang L, Lucak S, Gutman C, Dove LS, Covington PS, Lembo A.

Therap Adv Gastroenterol. 2019 Apr 15;12:1756284819841290. doi: 10.1177/1756284819841290. eCollection 2019.

9.

Update on the management of chronic idiopathic constipation.

Lacy BE.

Am J Manag Care. 2019 Mar;25(4 Suppl):S55-S62.

10.

Letter: meta-analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors' reply.

Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P.

Aliment Pharmacol Ther. 2019 May;49(9):1254-1255. doi: 10.1111/apt.15234. No abstract available.

PMID:
30977174
11.

A Novel, Duodenal-Release Formulation of a Combination of Caraway Oil and L-Menthol for the Treatment of Functional Dyspepsia: A Randomized Controlled Trial.

Chey WD, Lacy BE, Cash BD, Epstein M, Corsino PE, Shah SM.

Clin Transl Gastroenterol. 2019 Apr;10(4):e00021. doi: 10.14309/ctg.0000000000000021.

12.

Irritable Bowel Syndrome and Dietary Interventions.

Werlang ME, Palmer WC, Lacy BE.

Gastroenterol Hepatol (N Y). 2019 Jan;15(1):16-26.

13.

The willingness of patients with gastroparesis to take risks with medications.

Navas CM, Crowell MD, Lacy BE.

Aliment Pharmacol Ther. 2019 Feb;49(4):429-436. doi: 10.1111/apt.15112. Epub 2019 Jan 9.

PMID:
30628106
14.

Symptomatic Management of Gastroparesis.

Navas CM, Patel NK, Lacy BE.

Gastrointest Endosc Clin N Am. 2019 Jan;29(1):55-70. doi: 10.1016/j.giec.2018.08.005. Epub 2018 Sep 11. Review.

PMID:
30396528
15.

Functional Dyspepsia: Clinical Symptoms, Psychological Findings, and GCSI Scores.

Lacy BE, Everhart K, Crowell MD.

Dig Dis Sci. 2019 May;64(5):1281-1287. doi: 10.1007/s10620-018-5347-2. Epub 2018 Oct 31.

PMID:
30382539
16.

Introduction to the 80% by 2018 Special Issue.

Lacy BE, Spiegel B.

Am J Gastroenterol. 2018 Dec;113(12):1737-1738. doi: 10.1038/s41395-018-0387-y. Epub 2018 Oct 30. No abstract available.

17.

Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-Analysis of Randomized Control Trials.

Pittayanon R, Yuan Y, Bollegala NP, Khanna R, Lacy BE, Andrews CN, Leontiadis GI, Moayyedi P.

Am J Gastroenterol. 2019 Feb;114(2):233-243. doi: 10.1038/s41395-018-0258-6.

PMID:
30337705
18.

Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.

Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P.

Aliment Pharmacol Ther. 2018 Nov;48(10):1044-1060. doi: 10.1111/apt.15001. Epub 2018 Oct 8.

PMID:
30294792
19.

Review article: an analysis of safety profiles of treatments for diarrhoea-predominant irritable bowel syndrome.

Lacy BE.

Aliment Pharmacol Ther. 2018 Oct;48(8):817-830. doi: 10.1111/apt.14948. Epub 2018 Sep 7. Review.

20.

Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.

Ford AC, Lacy BE, Harris LA, Quigley EMM, Moayyedi P.

Am J Gastroenterol. 2019 Jan;114(1):21-39. doi: 10.1038/s41395-018-0222-5.

Supplemental Content

Loading ...
Support Center